Last updated on February 2020

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

Brief description of study

The purpose of this extension trial is to evaluate the long-term safety of tralokinumab.

Clinical Study Identifier: NCT03587805

Find a site near you

Start Over

LEO Pharma Investigational Site

North Bay, ON Canada
  Connect »